Complete response induced by fotemustine given as single agent in a patient with primary central nervous system non-Hodgkin aggressive lymphoma relapsed after high-dose chemotherapy and autologous stem cell support

MeSH terms

• Adult
• Antineoplastic Agents / therapeutic use
• Central Nervous System Neoplasms / drug therapy*
• Central Nervous System Neoplasms / pathology
• Central Nervous System Neoplasms / therapy
• Combined Modality Therapy
• Dose-Response Relationship, Drug
• Drug Therapy / methods
• Humans
• Lymphoma, Non-Hodgkin / drug therapy*
• Lymphoma, Non-Hodgkin / pathology
• Lymphoma, Non-Hodgkin / therapy
• Male
• Nitrosourea Compounds / therapeutic use*
• Organophosphorus Compounds / therapeutic use*
• Recurrence
• Stem Cell Transplantation / methods
• Transplantation, Autologous
• Treatment Outcome